Nat Rev Drug Discov. 2003 Apr;2(4):296-313.

Issues and progress with protein kinase inhibitors for cancer treatment.

Source

Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, Investigational Drug Branch, National Cancer Institute, 6130 Executive Blvd, Room 7131, Rockville, Maryland 20852, USA. danceyj@ctep.nci.nih.gov

Abstract

Identification of the key roles of protein kinases in cancer has led to extensive efforts to develop kinase inhibitors for the treatment of a wide range of cancers, and more than 30 such agents are now in clinical trials. Here, we consider the crucial issues in the development of kinase inhibitors for cancer, and discuss strategies to address the challenges raised by these issues in the light of preclinical and clinical experiences so far.

PMID:: 12669029; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Review Challenges of developing therapeutics that target signal transduction in patients with gynecologic and other malignancies. [J Clin Oncol. 2003]
Review Challenges of developing therapeutics that target signal transduction in patients with gynecologic and other malignancies.
Rowinsky EK. J Clin Oncol. 2003 May 15; 21(10 Suppl):175s-186s.
Review Protein kinase inhibitors as a therapeutic modality. [Acc Chem Res. 2003]
Review Protein kinase inhibitors as a therapeutic modality.
Levitzki A. Acc Chem Res. 2003 Jun; 36(6):462-9.
Review Targeting cancer with small molecule kinase inhibitors. [Nat Rev Cancer. 2009]
Review Targeting cancer with small molecule kinase inhibitors.
Zhang J, Yang PL, Gray NS. Nat Rev Cancer. 2009 Jan; 9(1):28-39.
PI3K inhibitors for cancer therapy: what has been achieved so far? [Curr Med Chem. 2009]
PI3K inhibitors for cancer therapy: what has been achieved so far?
Wu P, Liu T, Hu Y. Curr Med Chem. 2009; 16(8):916-30.
Review Protein kinase inhibitors: insights into drug design from structure. [Science. 2004]
Review Protein kinase inhibitors: insights into drug design from structure.
Noble ME, Endicott JA, Johnson LN. Science. 2004 Mar 19; 303(5665):1800-5.

See reviews... See all...

Cited by 32 PubMed Central articles

Metabolism of phosphatidylinositol 4-kinase IIIα-dependent PI4P Is subverted by HCV and is targeted by a 4-anilino quinazoline with antiviral activity. [PLoS Pathog. 2012]
Metabolism of phosphatidylinositol 4-kinase IIIα-dependent PI4P Is subverted by HCV and is targeted by a 4-anilino quinazoline with antiviral activity.
Bianco A, Reghellin V, Donnici L, Fenu S, Alvarez R, Baruffa C, Peri F, Pagani M, Abrignani S, Neddermann P, et al. PLoS Pathog. 2012 Mar; 8(3):e1002576. Epub 2012 Mar 8.
Erlotinib inhibits osteolytic bone invasion of human non-small-cell lung cancer cell line NCI-H292. [Clin Exp Metastasis. 2011]
Erlotinib inhibits osteolytic bone invasion of human non-small-cell lung cancer cell line NCI-H292.
Furugaki K, Moriya Y, Iwai T, Yorozu K, Yanagisawa M, Kondoh K, Fujimoto-Ohuchi K, Mori K. Clin Exp Metastasis. 2011 Oct; 28(7):649-59. Epub 2011 Jun 18.
Metabolic stability of 6,7-dialkoxy-4-(2-, 3- and 4-[18F]fluoroanilino)quinazolines, potential EGFR imaging probes. [Bioorg Med Chem. 2011]
Metabolic stability of 6,7-dialkoxy-4-(2-, 3- and 4-[18F]fluoroanilino)quinazolines, potential EGFR imaging probes.
Vasdev N, Dorff PN, O'Neil JP, Chin FT, Hanrahan S, VanBrocklin HF. Bioorg Med Chem. 2011 May 1; 19(9):2959-65. Epub 2011 Mar 21.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Issues and progress with protein kinase inhibitors for cancer treatment.
Issues and progress with protein kinase inhibitors for cancer treatment.
Nat Rev Drug Discov. 2003 Apr ;2(4):296-313.

PubMed
PI3K in lymphocyte development, differentiation and activation.
PI3K in lymphocyte development, differentiation and activation.
Nat Rev Immunol. 2003 Apr ;3(4):317-30.

PubMed
Long-term suppression of hepatitis B e antigen-negative chronic hepatitis B by 2...
Long-term suppression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy.
Hepatology. 2003 Apr ;37(4):756-63.

PubMed
Signaling from cAMP/PKA to MAPK and synaptic plasticity.
Signaling from cAMP/PKA to MAPK and synaptic plasticity.
Mol Neurobiol. 2003 Feb ;27(1):99-106.

PubMed
Investigating the regulation of one-carbon metabolism in Arabidopsis thaliana.
Investigating the regulation of one-carbon metabolism in Arabidopsis thaliana.
Plant Cell Physiol. 2003 Mar ;44(3):233-41.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: